The Caterpillar and Caterpillar Micro arterial embolization devices (BD) have received US Food and Drug Administration (FDA) clearance.
The Caterpillar devices utilise a novel dual action design that includes both nitinol fibre segments and an occlusive membrane, according to BD.
This is the eighth approval from the FDA for BD this year.
